Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ALM-412 by Almirall for Familial Adenomatous Polyposis: Likelihood of Approval
ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis. According to GlobalData, Phase...
Data Insights
ALM-412 by Almirall for Epidermolysis Bullosa: Likelihood of Approval
ALM-412 is under clinical development by Almirall and currently in Phase I for Epidermolysis Bullosa. According to GlobalData, Phase I...